Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 15.99% this year. Over the last six months, there has been a weaker performance of 10.75%. The price of ANGN fallen by 25.15% during the last 30 days period. For the last 5-days stocks have improved 19.16%.
Angion Biomedica Corp. (ANGN) has a current stock price of $0.94. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.89 after opening at $0.89. The stock’s low for the day was $0.80, and it eventually closed at $0.85.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Angion Biomedica Corp. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $2.04 on 06/24/22, while the lowest price during the same period was $0.46 on 03/21/23.
52-week price history of ANGN Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Angion Biomedica Corp.’s current trading price is -53.85% away from its 52-week high, while its distance from the 52-week low is 104.65%. The stock’s price range over this timeframe has been between $0.46 and $2.04. The shares of the Healthcare sector company recorded a trading volume of approximately 0.63 million for the day, which was comparatively higher than the average daily volume of 59090.0 over the last three months.
The Connection Between Financial Performance and Market Capitalization
Angion Biomedica Corp. (ANGN) has experienced a quarterly rise of 42.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.93M and boasts a workforce of 3 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6866, with a change in price of +0.0709. Similarly, Angion Biomedica Corp. recorded 76,926 in trading volume during the last 100 days, posting a change of +8.13%.
ANGN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ANGN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ANGN Stock Stochastic Average
Angion Biomedica Corp.’s raw stochastic average for the past 50 days is currently at 91.09%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 86.12%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.81% and 61.69%, respectively.